Gastrointestinal Toxicity Linked to Targeted Cancer Therapies in the United States
February 20, 2026
A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled “Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national patient protection.” continue reading »